These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 3872073)

  • 1. The effect of prostaglandin E2 on the initial immune response to herpes simplex virus infection.
    Baker DA; Thomas J
    Am J Obstet Gynecol; 1985 Mar; 151(5):586-90. PubMed ID: 3872073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of prostaglandins on the multiplication and cell-to-cell spread of herpes simplex virus type 2 in vitro.
    Baker DA; Thomas J; Epstein J; Possilico D; Stone ML
    Am J Obstet Gynecol; 1982 Oct; 144(3):346-9. PubMed ID: 6289665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective study of herpes simplex virus infection in a defined population in Houston, Texas.
    Adler-Storthz K; Dreesman GR; Kaufman RH; Melnick JL; Adam E
    Am J Obstet Gynecol; 1985 Mar; 151(5):582-6. PubMed ID: 2983557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrent infection with herpes simplex virus after marrow transplantation: role of the specific immune response and acyclovir treatment.
    Wade JC; Day LM; Crowley JJ; Meyers JD
    J Infect Dis; 1984 May; 149(5):750-6. PubMed ID: 6327849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of local gamma interferon in recurrent herpes simplex infection.
    Torseth JW; Merigan TC
    J Infect Dis; 1986 May; 153(5):979-84. PubMed ID: 3084668
    [No Abstract]   [Full Text] [Related]  

  • 6. Variation in lymphoproliferative responses during recrudescent orofacial herpes simplex virus infections.
    Vestey JP; Norval M; Howie S; Maingay J; Neill WA
    Clin Exp Immunol; 1989 Sep; 77(3):384-90. PubMed ID: 2553308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of T lymphocytes in cellular immune responses during herpes simplex virus infection in humans.
    Rasmussen L; Merigan TC
    Proc Natl Acad Sci U S A; 1978 Aug; 75(8):3957-61. PubMed ID: 308659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and immunological evaluation of oral ribavirin administration in recurrent herpes simplex infections.
    Palmieri G; Ambrosi G; Ferraro G; Agrati AM; Palazzini E
    J Int Med Res; 1987; 15(5):264-75. PubMed ID: 3315775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation and suppression of herpes simplex virus in a human T lymphoid cell line.
    Hammer SM; Richter BS; Hirsch MS
    J Immunol; 1981 Jul; 127(1):144-8. PubMed ID: 6263972
    [No Abstract]   [Full Text] [Related]  

  • 10. Suppression by progesterone of nonspecific in vitro lymphocyte stimulation in mice as a mechanism for the enhancement of herpes simplex virus type 2 vaginal infection.
    Baker DA; Phillips CA; Roessner K; Albertini RJ; Mann LI
    Am J Obstet Gynecol; 1980 Feb; 136(4):440-5. PubMed ID: 6243861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reactivation of herpes simplex virus infection by ultraviolet light and possible involvement of prostaglandins.
    Blyth WA; Hill TJ; Field HJ; Harbour DA
    J Gen Virol; 1976 Dec; 33(3):547-50. PubMed ID: 187729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of prostaglandin E2 and preincubation on lectin-stimulated proliferation of human T cell subsets.
    Gualde N; Goodwin JS
    Cell Immunol; 1982 Jul; 70(2):373-9. PubMed ID: 6215130
    [No Abstract]   [Full Text] [Related]  

  • 13. Transfer factor in the treatment of herpes simplex types 1 and 2.
    Khan A; Hansen B; Hill NO; Loeb E; Pardue AS; Hill JM
    Dermatologica; 1981; 163(2):177-85. PubMed ID: 6974662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diminished interferon-gamma and lymphocyte proliferation in neonatal and postpartum primary herpes simplex virus infection.
    Burchett SK; Corey L; Mohan KM; Westall J; Ashley R; Wilson CB
    J Infect Dis; 1992 May; 165(5):813-8. PubMed ID: 1314868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CXCL10/CXCR3-Dependent Mobilization of Herpes Simplex Virus-Specific CD8
    Srivastava R; Khan AA; Chilukuri S; Syed SA; Tran TT; Furness J; Bahraoui E; BenMohamed L
    J Virol; 2017 Jul; 91(14):. PubMed ID: 28468883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contrasting effects of prostaglandin E2 and indomethacin in modulating Con A-induced human lymphocyte proliferation and suppressor cell development.
    Skoldstam L; Zoschke D; Messner R
    Clin Immunol Immunopathol; 1982 Oct; 25(1):32-42. PubMed ID: 6217939
    [No Abstract]   [Full Text] [Related]  

  • 17. T cell immunity to herpes simplex viruses in seronegative subjects: silent infection or acquired immunity?
    Posavad CM; Wald A; Hosken N; Huang ML; Koelle DM; Ashley RL; Corey L
    J Immunol; 2003 Apr; 170(8):4380-8. PubMed ID: 12682275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Studies on the effect of herpes virus infections on human cell-mediated immunity. 1. Lymphocyte subpopulations in the peripheral blood from patients with herpes zoster and herpes simplex (author's transl)].
    Urushibata O
    Nihon Hifuka Gakkai Zasshi; 1977 Jul; 87(8):493-500. PubMed ID: 302873
    [No Abstract]   [Full Text] [Related]  

  • 19. Specific immunity after congenital or neonatal infection with cytomegalovirus or herpes simplex virus.
    Hayward AR; Herberger MJ; Groothuis J; Levin MR
    J Immunol; 1984 Nov; 133(5):2469-73. PubMed ID: 6207230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequential changes in T and B lymphocyte responses to Herpes simplex virus in man.
    Shillitoe EJ; Wilton JM; Lehner T
    Scand J Immunol; 1978; 7(5):357-66. PubMed ID: 307272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.